Presentation TCT 2016 Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia October 30, 2016
Presentation AHA Late Breaking Trials: What's more appropriate? IVUS or appropriate use criteria? Presenter: Gregg W. Stone January 19, 2016
Presentation TCT 2015 Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS) Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian October 15, 2015
Presentation TCT 2015 What Defines Severe MR Post-AHA/ACC Guidelines? Presenter: Jeroen J. Bax, Paul A. Grayburn October 15, 2015
Presentation TVT 2015 ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Disagree? Presenter: Gregg W. Stone, Alec S. Vahanian, John D. Carroll June 05, 2015
Presentation TVT 2015 ESC/EACTS 2012 and ACC/AHA 2014 Valvular Heart Disease Guidelines: Where Do They Agree? Presenter: Gregg W. Stone, Alec S. Vahanian, Allan Schwartz June 05, 2015
Presentation AHA 2014 Late Breaking Trials: Duration of Dual Anti-platelet Therapy after Stenting Presenter: Gregg W. Stone December 01, 2014
Presentation AHA 2014 Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent Presenter: Dean J. Kereiakes November 16, 2014
Presentation AHA 2014 Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial Presenter: C.Kaiser November 16, 2014
Presentation AHA 2014 Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery Presenter: S. van Diepen November 16, 2014
Presentation TCT 2014 Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara September 15, 2014
Presentation TCT 2014 ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler September 13, 2014
Presentation TCT 2014 Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow September 13, 2014
Presentation TVT 2014 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: Catherine M. Otto June 05, 2014
Presentation TCT 2013 Introduction and AHA Policy Statement Presenter: H. Robert Superko October 31, 2013
Presentation Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI Presenter: Stephan Windecker October 29, 2013
Presentation TCT 2013 Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies Presenter: Alec Vahanian October 27, 2013
Presentation TCT 2013 Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar January 31, 2013
Presentation AHA 2012 Endovascular Treatment for Infrainguinal Vessels in Patients with Critical Limb Ischemia: OLIVE Registry, a Prospective, Multicenter Study in Japan with 12-month Follow-up Presenter: Masato Nakamura November 06, 2012